- Home
- JLL vs ASND Comparison
JLL vs ASND Comparison
Compare JLL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JLL | ASND |
|---|---|---|
| Founded | 1997 | 2006 |
| Country | United States | Denmark |
| Employees | 48000 | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 15.0B |
| IPO Year | 1997 | 2014 |
Fundamental Metrics
Financial Performance| Metric | JLL | ASND |
|---|---|---|
| Price | $304.88 | $224.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 21 |
| Target Price | ★ $416.70 | $306.03 |
| AVG Volume (30 Days) | 403.5K | ★ 757.5K |
| Earning Date | 10-28-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.13 | N/A |
| EPS | ★ 7.91 | N/A |
| Revenue | ★ $26,115,600,000.00 | N/A |
| Revenue This Year | $11.32 | $90.81 |
| Revenue Next Year | $7.92 | $46.89 |
| P/E Ratio | $39.22 | ★ N/A |
| Revenue Growth | ★ 11.45 | N/A |
| 52 Week Low | $259.83 | $186.05 |
| 52 Week High | $393.84 | $282.15 |
Technical Indicators
Market Signals| Indicator | JLL | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 39.60 | 41.29 |
| Support Level | $280.51 | $216.52 |
| Resistance Level | $311.87 | $249.89 |
| Average True Range (ATR) | 9.00 | 5.64 |
| MACD | 1.40 | 0.75 |
| Stochastic Oscillator | 57.63 | 41.75 |
Price Performance
Historical ComparisonAbout JLL Jones Lang LaSalle Incorporated
Jones Lang LaSalle is a global commercial real estate services and investment management company that helps clients buy, build, occupy, manage, and invest in property across office, industrial, retail, multifamily, hotel, and data center assets. For over 200 years, clients have trusted JLL, a Fortune 500 company, tracing its roots to firms including LaSalle Partners (founded in Chicago in 1968) and the centuries-old London firm Jones Lang Wootton, which merged in 1999 to form the modern JLL. Today, the firm is a leading global commercial real estate services and investment management company with operations in over 80 countries and a global workforce of more than 113,000, as of early 2026.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.